$2.68T
Total marketcap
$59.71B
Total volume
BTC 49.90%     ETH 17.10%
Dominance

IDEXX Laboratories, Inc. IDXX.VI Stock

467 EUR {{ price }} 0.951144% {{change_pct}}%
COUNTRY
Austria
Exchange
Vienna
Market Cap
38.79B EUR
LOW - HIGH [24H]
463.7 - 467 EUR
VOLUME [24H]
0 EUR
{{ volume }}
P/E Ratio
49.00
Earnings per share
9.53 EUR

IDEXX Laboratories, Inc. Price Chart

IDEXX Laboratories, Inc. IDXX.VI Financial and Trading Overview

IDEXX Laboratories, Inc. stock price 467 EUR
Previous Close 435.6 EUR
Open 432.4 EUR
Bid 434.6 EUR x 0
Ask 442.5 EUR x 0
Day's Range 432.4 - 435.6 EUR
52 Week Range 312.5 - 480.85 EUR
Volume 0 EUR
Avg. Volume 0 EUR
Market Cap 36.16B EUR
Beta (5Y Monthly) 1.191901
PE Ratio (TTM) 54.654957
EPS (TTM) 9.53 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

IDXX.VI Valuation Measures

Enterprise Value 37.37B EUR
Trailing P/E 54.654957
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 10.538399
Price/Book (mrq) 42.988255
Enterprise Value/Revenue 10.891
Enterprise Value/EBITDA 35.773

Trading Information

IDEXX Laboratories, Inc. Stock Price History

Beta (5Y Monthly) 1.191901
52-Week Change 36.74%
S&P500 52-Week Change 20.43%
52 Week High 480.85 EUR
52 Week Low 312.5 EUR
50-Day Moving Average 437.73 EUR
200-Day Moving Average 412.39 EUR

IDXX.VI Share Statistics

Avg. Volume (3 month) 0 EUR
Avg. Daily Volume (10-Days) 0 EUR
Shares Outstanding 83M
Float 82.16M
Short Ratio N/A
% Held by Insiders 0.93%
% Held by Institutions 92.79%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 20.37%
Operating Margin (ttm) 27.12%
Gross Margin 59.70%
EBITDA Margin 30.44%

Management Effectiveness

Return on Assets (ttm) 21.54%
Return on Equity (ttm) 94.42%

Income Statement

Revenue (ttm) 3.43B EUR
Revenue Per Share (ttm) 41.2 EUR
Quarterly Revenue Growth (yoy) 7.59%
Gross Profit (ttm) 2B EUR
EBITDA 1.04B EUR
Net Income Avi to Common (ttm) 699.18M EUR
Diluted EPS (ttm) 7.97
Quarterly Earnings Growth (yoy) 10.40%

Balance Sheet

Total Cash (mrq) 111.37M EUR
Total Cash Per Share (mrq) 1.34 EUR
Total Debt (mrq) 1.32B EUR
Total Debt/Equity (mrq) 156.96 EUR
Current Ratio (mrq) 1.079
Book Value Per Share (mrq) 10.133

Cash Flow Statement

Operating Cash Flow (ttm) 612.19M EUR
Levered Free Cash Flow (ttm) 398.99M EUR

Profile of IDEXX Laboratories, Inc.

Country Austria
State ME
City Westbrook
Address One IDEXX Drive
ZIP 04092
Phone 207 556 0300
Website https://www.idexx.com
Industry Diagnostics & Research
Sector(s) Healthcare
Full Time Employees 10780

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; OPTI SARS-CoV-2 RT-PCR test kit for human COVID-19 testing; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Q&A For IDEXX Laboratories, Inc. Stock

What is a current IDXX.VI stock price?

IDEXX Laboratories, Inc. IDXX.VI stock price today per share is 467 EUR.

How to purchase IDEXX Laboratories, Inc. stock?

You can buy IDXX.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for IDEXX Laboratories, Inc.?

The stock symbol or ticker of IDEXX Laboratories, Inc. is IDXX.VI.

Which industry does the IDEXX Laboratories, Inc. company belong to?

The IDEXX Laboratories, Inc. industry is Diagnostics & Research.

How many shares does IDEXX Laboratories, Inc. have in circulation?

The max supply of IDEXX Laboratories, Inc. shares is 83.07M.

What is IDEXX Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?

IDEXX Laboratories, Inc. PE Ratio is 49.00315000 now.

What was IDEXX Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?

IDEXX Laboratories, Inc. EPS is 9.53 EUR over the trailing 12 months.

Which sector does the IDEXX Laboratories, Inc. company belong to?

The IDEXX Laboratories, Inc. sector is Healthcare.